SEC Filings

SEC Filings

Filing date Form Description View
S-3MEF

Registration of up to an additional 20% of securities for any offering registered on a S-3

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

© 2007 - 2024   aTyr Pharma.   Legal   Privacy Policy